Research interests
Our research deals with materials and processes at colloidal (nanometer to micrometer) length scales. The focus is on synthesis and processing of particulate, colloidal and biomolecular systems.
Particle formation processes/pharmaceutical engineering
Numerous pharmaceutical particulates are formed through antisolvent driven processes, where two solutions are mixed in order to create a thermodynamic driving force for particle formation due to a limited solubility of one or more solutes in the resulting solvent mixture. Such processes are often mixing controlled and can lead to a wide range of intermediate and/or metastable liquid or solid phases. We study kinetics and mechanisms of these processes in order to design and novel continuous processes for manufacturing of nanostructured particles for various pharmaceutical applications. We also study subsequent downstream processes and their effects on resulting particulate products.
Protein Aggregation
Understanding, controlling and utilizing colloidal interactions of proteins is crucial for their downstream processing, including purification, sterilization and storage. Protein interactions with each other determine whether they stay stable in solution or whether they aggregate. Understanding and tuning of protein interactions is thus necessary for improvement of the lifetime stability of therapeutic proteins as well as for rational development of novel separation and sensing procedures for bioprocessing. In fact, there are numerous issues in biotechnology and biomedical engineering, where protein aggregation phenomena have been identified as key factors controlling our success in producing, sensing, handling, and applying biomaterials and therapeutics as desired. We study protein aggregation in solutions under non-equilibrium conditions. The proteins of interest include enzymes and therapeutic proteins in applications such as heat treatment or bioseparations. The modelling work is focused in detailed scattering and spectroscopic characterisation of aggregating protein systems as well as on development and validation of population balance models describing how the mass distribution, structure and activity of protein aggregates evolve in time.
Professional activities
- Multi-sensor Measurements For Quantitative Particle Size And Concentration Information in Crystal Slurries
- Contributor
- 24/4/2018
- MULTI-SENSOR MEASUREMENTS OF QUANTITATIVE PARTICLE SIZE AND SHAPE INFORMATION
- Contributor
- 20/6/2017
- Extracting and monitoring particle size distribution information for pharmaceutical crystallisation process using spatially and angularly resolved Visible-NIR Spectra
- Contributor
- 13/6/2017
- Modelling of particle size and shape distribution in pharmaceutical suspensions and the effects on UV-vis-NIR
- Contributor
- 10/5/2017
- European Summer School on Crystal Nucleation
- Invited speaker
- 20/6/2016
- Crystallize COST Action CM1402 Annual Meeting
- Keynote/plenary speaker
- 6/4/2016
more professional activities
Projects
- GSK PhD studentship top up
- Sefcik, Jan (Principal Investigator)
- Period 01-Oct-2018 - 30-Sep-2022
- Doctoral Training Partnership (DTP 2016-2017 University of Strathclyde) | McKechnie, David
- Sefcik, Jan (Principal Investigator) Johnston, Karen (Co-investigator) McKechnie, David (Research Co-investigator)
- Period 01-Jun-2017 - 01-Dec-2020
- CMAC Core project: Antisolvent
- Florence, Alastair (Principal Investigator) Sefcik, Jan (Co-investigator)
- Period 01-Oct-2017 - 30-Sep-2018
- Placement Agreement
- Sefcik, Jan (Principal Investigator)
- Period 08-Jan-2018 - 10-Apr-2018
- Enabling manufacturing of Functional Nanomaterials
- Zimbitas, Georgina (Researcher) Sefcik, Jan (Principal Investigator)
- his year, the global demand for nanomaterial, which is already a multi-billion$ industry, will have grown 2.5-fold since 2012. Current nanomaterials production methods are at least 1000 times more wasteful when compared to the production of bulk and fine chemicals. Consequently there is an urgent need to develop green production methods for nanomaterials which can allow greater control over materials properties, yet require less energy, produce less waste (i.e. eco-friendly) and are cost-effective. Nature produces more than 60 distinct inorganic nanomaterials (e.g. CaCO3, Fe3O4, silica) on the largest of scales through self-assembly under ambient conditions (biomineralisation). Although biological methods for nanomaterials synthesis (e.g. using microorganisms or complex enzymes) are effective in reducing environmental burden, they are expensive, inefficient and/or currently not scalable to industrial production. We will adopt a synthetic biology (SynBim) approach, which is one of the EPSRC's core strategic themes, by harnessing the biological principles to design advanced nanomaterials leading to novel manufacturing methods. SynBim is a very powerful tool for the production of high-precision advanced functional nanomaterials and our approach marries two of the "8 great technologies for the future" ("Synthetic Biology" and "Advanced Nanomaterials"). Instead of using cells or microbes, our SynBim strategy uses synthetic molecules (SynBim additives) inspired from biomineralisation. SynBim produces a wide range of well-defined and tunable nanomaterials under mild (ambient) conditions, quickly and with little waste. Our SynBim approach offers the potential for high-yields, like the traditional chemical precipitation method, together with the precision, customisation, efficiency and low waste of biomineralisation.The bulk of research on bioinspired synthesis of nanomaterials has been performed at small scales and, although there are good opportunities for developing nanomaterials manufacturing based on bioinspired approaches, there are no reports on larger-scale investigations. Adopting a bioinspired SynBim approach, this project will enable the controlled synthesis and scalability of silica and magnetic nanoparticles (SNP and MNP) which are worth ~$11 billion globally. These methods are far more amenable to scale-up and can truly be considered 'green'. This SynBim process can reduce the manufacturing carbon footprint (by >90%), thus providing a significant cost benefit to industry.
- Period 01-Dec-2016 - 30-Nov-2020
- Doctoral Training Centre In Continuous Manufacturing And Crystallisation / RS4912
- Florence, Alastair (Principal Investigator) Sefcik, Jan (Co-investigator)
- Period 01-Jul-2012 - 01-Jul-2012
more projects
Address
Chemical and Process Engineering
James Weir Building
James Weir Building
Location Map
View University of Strathclyde in a larger map